Gintsburg names start dates for clinical trials of cancer vaccine

MOSCOW, July 24 Clinical trials of a cancer vaccine may begin in the fall of 2025, said Alexander Ginzburg, director of the Gamaleya National Research Center of Epidemiology and Microbiology.
«Now I will say that sometime in the fall,» Ginzburg told reporters, answering a question about when clinical trials of a cancer vaccine would begin.
Earlier, Ginzburg reported that the cancer vaccine would be personalized, that is, made for each patient individually, and artificial intelligence would help in its development, which would analyze the parameters of the tumor and issue a «blueprint» for the future drug, and specialists would then make the vaccine within a week based on it.